Trial Profile
A Long-Term, Open-Label Extension Study to Investigate the Long-Term Safety of SYR-322 When Used in Combination With Thiazolidine in Subjects With Type 2 Diabetes in Japan [EXTENSION OF 700060214]
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 20 Mar 2014
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary) ; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Takeda
- 20 Mar 2014 New trial record